Objective We conducted the first systematic review and meta-analysis to estimate the
specific prevalence of apparent treatment-resistant, pseudo-resistant and true-resistant …

Hypertension is the most common chronic disease and the leading risk factor for disability
and premature deaths in the world, accounting for more than 9 million deaths annually …

Hypertensive nephropathy is characterized by long-term damage to renal tissues by chronic
uncontrolled hypertension, and ultimately leads to the development of renal fibrosis. The …

Resistant hypertension is defined as a lack of ambulatory blood pressure response to
optimized medical treatment after exclusion of secondary hypertension in patients who are …

Hypertension is one of the leading causes of disability-adjusted life years and mortality, with
approximately 15% prevalence worldwide. Most patients with hypertension from low-to high …

The term RH describes a subgroup of hypertensive patients whose BP is uncontrolled
despite the use of at least three antihypertensive drugs in an appropriate combination at …

The definition of resistant hypertension (RHT) has been updated to include failure to achieve
target blood pressure (BP) despite treatment with≥ 3 antihypertensive drugs, including …

Objectives Immune system activation plays a role in resistant hypertension (RHTN)
pathogenesis. The clinical effect of the prognostic nutritional index (PNI) on patients with …

The publication of the first non-randomised proof-of-concept trial of renal denervation as a
treatment modality in treatment--resistant hypertension set the stage for a search for novel …

Background: Human cellular repressor of E1A-stimulated genes (CREG) is a secreted
glycoprotein that attenuates angiotensin II-induced hypertension, alleviates myocardial …